Generate a tailored SOP for Dr. Mikkel Christensen. Improve your application with a focused, well-structured draft.
Mikkel Bring Christensen is a Clinical Professor in Clinical Pharmacology at the University of Copenhagen, actively engaging in research that focuses on clinical metabolism, toxicology, and pharmacology. His significant contributions have advanced the understanding of clinical action related to endogenous gut hormones and peptide-based therapeutics, particularly in the contexts of diabetes, postprandial metabolism, appetite regulation, glucose, and bone homeostasis. He has been involved in metabolic research that led to the patent (WO2016034186A1) currently being explored by Antag Therapeutics for treating obesity and cardiometabolic disorders. Since 2013, he has researched medication overdoses and experimental treatments for medication poisonings, influencing guidelines for treating poisoned patients. In 2016, he initiated the Polypharmacy Outpatient Clinic at Copenhagen University Hospital, addressing complex interventions that reduce medication use while improving patient survival and quality of life. His current research endeavors aim to promote rational pharmacotherapy with a focus on diagnostic and therapeutic aspects related to patients experiencing overdoses and chronic metabolic diseases within a multi-morbidity context.
Focuses on clinical, social, and cognitive psychology.